There are currently 402 studies in the GENERA database.

Advanced Search

General Information

Document type
  • Peer-reviewed journal article
GE organism
  • potato
GE trait
  • quality
Country
  • Germany

Results

Efficacy
  • positive effect

Zeaxanthin is bioavailable from genetically modified zeaxanthin-rich potatoes.

Bub, A; Möseneder, J; Wenzel, G; Rechkemmer, G; Briviba, K
European Journal of Nutrition. 2008 March. 47(2):99-103

Link to full text (journal may charge for access)

PMID: 18320254 DOI: 10.1007/s00394-008-0702-2 ISSN: 1436-6215

Abstract

The carotenoid zeaxanthin accumulates in the human macula lutea and protects retinal cells from blue light damage. However, zeaxanthin intake from food sources is low. Increasing zeaxanthin in common foods such as potatoes by traditional plant breeding or by genetic engineering could contribute to an increased intake of this carotenoid and, consequently, to a decreased risk of age-related macular degeneration. Our aim was to investigate whether zeaxanthin from genetically modified zeaxanthin-rich potatoes is bioavailable in humans. Three men participated in this randomized, controlled double-blinded, crossover pilot study. All subjects consumed 1,100 g of mashed potatoes, either genetically modified (Solanum tuberosum L. var. Baltica GM47/18; 3 mg zeaxanthin) or wild-type control potatoes (Solanum tuberosum L. var. Baltica; 0.14 mg zeaxanthin). A second treatment was followed after a 7-day wash-out period. The concentration of zeaxanthin was significantly increased in chylomicrons after consumption of genetically modified potatoes and 0.27 mg of the 3 mg zeaxanthin dose could be detected in chylomicrons. Consumption of control potatoes had no effect on concentrations of zeaxanthin in chylomicrons. After normalization of chylomicron zeaxanthin for plasma triacylglycerol, the time course of zeaxanthin concentrations peaked at 7 h after consumption of genetically modified potatoes. There were no significant differences in the concentrations of other major potato carotenoids such as lutein and beta-carotene in chylomicrons after consumption of genetically modified and wild type control potatoes. Thus, consumption of zeaxanthin-rich potatoes significantly increases chylomicron zeaxanthin concentrations suggesting that potentially such potatoes could be used as an important dietary source of zeaxanthin.

Keywords

zeaxanthin; bioavailability; age-related macular degeneration; potato

Funding

Funding source
  • German Federal Ministry of Education and Research
Funding country
  • Germany
Funding type
  • government

Links to outside analysis of this resource

Please contact us if you know of an independent summary or analysis of this resource.

Cite this study

MLA

Bub, A, J Möseneder, G Wenzel, G Rechkemmer, K Briviba. "Zeaxanthin is bioavailable from genetically modified zeaxanthin-rich potatoes.." European Journal of Nutrition 47.2 (2008): 99-103. Web. 21 Nov. 2018.

APA

Bub, A., Möseneder, J., Wenzel, G., Rechkemmer, G., & Briviba, K. (2008). Zeaxanthin is bioavailable from genetically modified zeaxanthin-rich potatoes.. European Journal of Nutrition, 47(2), 99-103. doi:10.1007/s00394-008-0702-2

Please verify citations before use, citations are automatically generated based on information stored within the GENERA database and therefore may or may not be correct.